{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:17:30Z","timestamp":1777583850838,"version":"3.51.4"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD103085"],"award-info":[{"award-number":["K12HD103085"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Cervical cancer disproportionately impacts women in low- and middle-income countries (LMICs). The World Health Organization\u2019s (WHO) 90\/70\/90 strategy aims to eliminate cervical cancer by 2030 by increasing HPV vaccination coverage to 90%, screening 70% of eligible women, and effectively treating 90% of those with abnormal results by 2030, potentially preventing 62 million deaths in LMICs. LMICs, however, struggle with limited access to cervical precancer treatment, in part due to a lack of trained professionals and weak health systems. Effective non-surgical, self-administered, which have demonstrated efficacy in high-income countries, could bridge the treatment gap in LMICs and may be more scalable and cost-effective than provider-administered therapies. To inform feasibility studies in LMICs, data are needed on the role of male partners in influencing the acceptability and uptake of self-administered topical therapies, including their support of recommended abstinence and contraception guidelines associated with these therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between November 2022 and April 2023, we conducted five focus group discussions (FGDs) with men aged 25 to 65 years in Kenya to explore their perspective and perceived support regarding their female partners using topical self-administered therapies for cervical precancer treatment. The FGDs were moderated by local qualitative research assistants and conducted in local languages, transcribed, coded, and analyzed using qualitative description.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-nine male participants meeting the eligibility criteria participated in five FGDs. The mean age of participants was 42.5 years. Most participants, 79.5%, had a female partner with a history of cervical precancer treatment, 5.1% did not, and 15.4% were unsure of their female partner\u2019s prior precancer treatment history. The study aimed to assess men\u2019s support of their female partners\u2019 use of topical therapies for treating cervical precancer. We find that male participants strongly express acceptance and willingness to support their wives or partners in using such therapies, if available. Reported supportive behavior included permitting the use of the therapies and support of maintaining abstinence during the recommended times. Additionally, participants desired male involvement in clinic and community-based education about topical therapies to facilitate widespread support.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of self-administered topical therapies for cervical precancer treatment, if supported by efficacy studies in LMICs, may support achieving the WHO\u2019s 2030 goal of 90% treatment access. We find that with adequate education, men express overwhelming support of their female partner\u2019s use of topical therapies, including adherence to abstinence and contraception guidelines.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1360337","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:26:11Z","timestamp":1710249971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["\u201cThere is nothing that can prevent me from supporting her:\u201d men\u2019s perspectives on their involvement and support of women\u2019s use of topical therapy for cervical precancer treatment in Kenya"],"prefix":"10.3389","volume":"14","author":[{"given":"Chemtai","family":"Mungo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konyin","family":"Adewumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everlyn","family":"Adoyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Zulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supreet Kaur","family":"Goraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cirillus","family":"Ogollah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackton","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e M.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Rahangdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"B1","unstructured":"Cervical Cancer Elimination Initiative2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30533-3","article-title":"Cervical cancer: lessons learned from neglected tropical diseases","volume":"7","author":"Knaul","year":"2019","journal-title":"Lancet Glob Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.16176","article-title":"Cervical cancer as a global concern: contributions of the dual epidemics of HPV and HIV","volume":"322","author":"Chibwesha","year":"2019","journal-title":"JAMA United States;"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-12547-9","article-title":"Cervical cancer screening coverage and its related knowledge in southern Malawi","volume":"22","author":"Gerstl","year":"2022","journal-title":"BMC Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00406-0","article-title":"Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study","volume":"11","author":"Frick","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B9","article-title":"Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV-testing approach","author":"Mungo","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12191","article-title":"Treatment of cervical intraepithelial lesions","author":"Castle","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13485","article-title":"Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africaa","volume":"152","author":"Rohner","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1745506520914804","DOI":"10.1177\/1745506520914804","article-title":"Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi","volume":"16","author":"Cubie","year":"2020","journal-title":"Womens Health (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.06.035","article-title":"Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya","volume":"124","author":"Khozaim","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"B15","article-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention","year":"2021"},{"key":"B16","unstructured":"P16INK4a as a progression\/regression tumour marker in LSIL cervix lesions: our clinical experience2024"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13171","article-title":"Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach","volume":"152","author":"Mungo","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3530-y","article-title":"Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: Retrospective cohort study","volume":"16","author":"Msyamboza","year":"2016","journal-title":"BMC Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4236\/ojog.2013.33058","article-title":"Same day colposcopic examination and loop electrosurgical excision procedure (LEEP) presents minimal overtreatment and averts delay in treatment of cervical intraepithelial neoplasia in Kenyatta National Hospital, Kenya","volume":"3","author":"Muruka","year":"2013","journal-title":"Open J Obstet Gynecol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199912000-00010","article-title":"Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: A randomized trial","volume":"94","author":"Maiman","year":"1999","journal-title":"Obstet Gynecol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.12.042","article-title":"Topical 5-flourourcil for treamtent of cervical intraepithelial Neoplasia 2 : a Randomized Controlled Trial. The American","volume":"210","author":"Rahangdale","year":"2014","journal-title":"J Obstet Gynecol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14983","article-title":"Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2\/3","volume":"163","author":"Desravines","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.12.035","article-title":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"157","author":"Trimble","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004384","article-title":"Topical imiquimod for the treatment of high-grade squamous intraepithelial lesions of the cervix: A randomized controlled trial","volume":"137","author":"Fonseca","year":"2021","journal-title":"Obstet gynecol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2012.09.006","article-title":"Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical\/vaginal intraepithelial neoplasia","volume":"51","author":"Lin","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.08.018","article-title":"Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review","volume":"139","author":"De Witte","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147917","article-title":"A single-arm, proof-of-concept trial of lopimune (Lopinavir\/ritonavir) as a treatment for HPV-related pre-invasive cervical disease","volume":"11","author":"Hampson","year":"2016","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100608","DOI":"10.1016\/j.gore.2020.100608","article-title":"Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: A narrative review","volume":"33","author":"Desravines","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000414","article-title":"Topical imiquimod treatment of high-grade cervical intraepithelial neoplasia (TOPIC-3): A nonrandomized multicenter study","volume":"45","author":"Hendriks","year":"2022","journal-title":"J Immunother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/gyn.2019.0076","article-title":"Low dose 5-fluorouracil intravaginal therapy for the treatment of cervical intraepithelial neoplasia 2\/3: A case series","volume":"36","author":"Desravines","year":"2020","journal-title":"J Gynecol Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31825bc6e8","article-title":"Treatment of cervical intraepithelial neoplasia with topical imiquimod: A randomized controlled trial","volume":"120","author":"Grimm","year":"2012","journal-title":"Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.01.033","article-title":"Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial","volume":"165","author":"Polterauer","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B34","article-title":"WHO Model List of Essential Medicines - 23rd List","year":"2023"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2183769","DOI":"10.1080\/14767058.2023.2183769","article-title":"Association between loop electrosurgical excision procedure and adverse pregnancy outcomes: a meta-analysis","volume":"36","author":"Liu","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40748-019-0105-9","article-title":"Facility readiness in low and middle-income countries to address care of high risk\/ small and sick newborns","volume":"5","author":"Narayanan","year":"2019","journal-title":"Matern Health Neonatol Perinatol"},{"key":"B37","article-title":"High-level global commitments implementing the population and development agenda","author":"Beyond","year":"2014","journal-title":"ICPD Beyond"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2307\/2991918","article-title":"Men as partners in reproductive health: from issues to action","volume":"24","author":"Wegner","year":"1998","journal-title":"Int Perspect Sex Reprod Health"},{"key":"B39","volume-title":"Policy approaches to engaging men and boys in achieving gender equality and health equity","year":"2010"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/dah312","article-title":"Evaluating men\u2019s involvement as a strategy in sexual and reproductive health promotion","volume":"19","author":"Sternberg","year":"2004","journal-title":"Health Promot Int"},{"key":"B41","volume-title":"WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women","year":"2013"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2051223","DOI":"10.1080\/16549716.2022.2051223","article-title":"Understanding the meanings of male partner support in the adherence to therapy among HIV-positive women: a gender analysis","volume":"15","author":"Triulzi","year":"2022","journal-title":"Glob Health Action"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-019-0804-4","article-title":"Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya","volume":"19","author":"Adewumi","year":"2019","journal-title":"BMC Womens Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224692","article-title":"Male support for cervical cancer screening and treatment in rural Ghana","volume":"14","author":"Binka","year":"2019","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280052","article-title":"Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda","volume":"18","author":"de Fouw","year":"2023","journal-title":"PloS One"},{"key":"B46","first-page":"1","volume-title":"Data Saturation. The International Encyclopedia of Communication Research Methods","author":"Faulkner","year":"2017"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2002.02424.x","article-title":"Journeying from the philosophical contemplation of constructivism to the methodological pragmatics of health services research","volume":"40","author":"Appleton","year":"2002","journal-title":"J Adv Nurs"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10433-010-0168-y","article-title":"Language differences in qualitative research: is meaning lost in translation","volume":"7","author":"Van Nes","year":"2010","journal-title":"Eur J Ageing"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1098-240X","article-title":"Whatever happened to qualitative description","volume":"23","author":"Sandelowski","year":"2000","journal-title":"Res Nurs Health"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/07399332.2019.1615914","article-title":"Spousal support and knowledge related to cervical cancer screening: are Sub-Saharan African immigrant (SSAI) men interested","volume":"30","author":"Adegboyega","year":"2019","journal-title":"Health Care Women Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"49901","DOI":"10.1136\/bmjopen-2021-049901","article-title":"Barriers to follow-up after an abnormal cervical cancer screening result and the role of male partners: a qualitative study","volume":"11","author":"Chapola","year":"2021","journal-title":"BMJ Open"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0950-5","article-title":"Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of \u201cunderstanding\u201d","volume":"19","author":"Montgomery","year":"2015","journal-title":"AIDS Behav J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14405","article-title":"Male partner influence on Women\u2019s choices and utilisation of family planning services in Mufulira district, Zambia","volume":"9","author":"Nkonde","year":"2023","journal-title":"Heliyon"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-010-9806-9","article-title":"The importance of male partner involvement for women\u2019s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe","volume":"15","author":"Montgomery","year":"2010","journal-title":"AIDS Behav J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002311","article-title":"Topical 5-fluorouracil for women with high-grade vaginal intraepithelial neoplasia","volume":"130","author":"Fiascone","year":"2017","journal-title":"Obstet gynecol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.ssmph.2021.100773","article-title":"Women\u2019s autonomy in household decision-making and safer sex negotiation in sub-Saharan Africa: An analysis of data from 27 Demographic and Health Surveys","volume":"14","author":"Seidu","year":"2021","journal-title":"SSM-Population Health"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.17.2173","article-title":"Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial","volume":"294","author":"Denny","year":"2005","journal-title":"JAMA"},{"key":"B58","unstructured":"Comprehensive Cervical Cancer Control: A Guide to Essential Practice2014"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmwh.2005.04.004","article-title":"Cryotherapy treatment for cervical intraepithelial neoplasia: women\u2019s experiences in Peru","volume":"50","author":"Coffey","year":"2005","journal-title":"J Midwife Womens Health"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31822b0991","article-title":"Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women","volume":"118","author":"Woo","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-023-05851-8","article-title":"An examination of the factors associated with male partner attendance in antenatal care in India","volume":"23","author":"Paul","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"B62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.11604\/pamj.2023.44.189.38293","article-title":"Barriers to male partner accompaniment and participation in maternal and child health care in Thika and Kiambu Level Five Hospital, Kenya","volume":"44","author":"Okwako","year":"2023","journal-title":"Pan Afr Med J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bmjsrh-2019-200503","article-title":"Concerns about disclosing a high-risk cervical human papillomavirus (HPV) infection to a sexual partner: a systematic review and thematic synthesis","volume":"47","author":"Bennett","year":"2021","journal-title":"BMJ Sex Reprod Health"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1360337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:26:16Z","timestamp":1710249976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1360337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":63,"alternative-id":["10.3389\/fonc.2024.1360337"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1360337","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"article-number":"1360337"}}